Jul 9, 2023, 09:28
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms – Uwe Platzbecker
Inflammation is a novel target for therapeutic interventions in myeloid neoplasms. Specific subsets of LR-MDS may benefit and others may probably not. More work needed to better understand. Thanks to Marie Schneider, Clara Rolfs, Michael Cross and the entire MDS team!
For article: Click here
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 02:34
Nov 19, 2024, 02:18
Nov 18, 2024, 22:22
Nov 18, 2024, 22:02
Nov 18, 2024, 21:55
Nov 18, 2024, 20:54